Some people experience relief from the side effects of constipation, while others may have temporary bouts of diarrhea
It has been a very effective medication for lowering blood sugar for many years, with the added benefit of weight loss .[1] In response to the weight loss seen in patients with type II diabetes, Novo Nordisk sent semaglutide into FDA trials for approval as a weight loss medication
Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomised controlled trials
Although semaglutide and liraglutide belong to the same class of drugs, GLP-1 receptor agonists, they differ in efficacy, indications, safety profile, route of administration, and dosing schedules
Body weight was also reduced with oral semaglutide versus placebo in healthy subjects